{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-025071","form_type":"8-K","ticker":"NCSM","cik":"0001692427","company_name":"NCS Multistage Holdings, Inc.","filed_at":"2026-07-30T20:29:14+00:00","discovered_at":"2026-07-30T20:30:00.216301+00:00","generated_at":"2026-07-30T20:30:10.704193+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NCS Multistage Q2 net loss $4.6M vs $0.9M income YoY; revenue up 5% to $38.4M","bullets":["Net loss per share $(1.71) vs diluted EPS $0.34 in Q2 2025; adjusted EBITDA $1.9M vs $2.2M.","Total revenues $38.4M (+5% YoY) driven by Repeat Precision and U.S. tracer diagnostics.","Cash $31.3M, total debt $7.5M (finance leases); ABL facility undrawn with $14.5M borrowing base.","Pending combination with Weatherford noted; professional fees increased due to strategic activities.","ResMetrics acquisition (July 2025) contributed $2.3M services revenue in Q2 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-025071","json":"https://secwatch.observer/filing/0001437749-26-025071.json","markdown":"https://secwatch.observer/filing/0001437749-26-025071.md","text":"https://secwatch.observer/filing/0001437749-26-025071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1692427/000143774926025071/0001437749-26-025071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1692427/000143774926025071/ncsm20260515_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-30T20:30:10.704193+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}